U.S. Remote Therapeutic Monitoring Market (2026 - 2033) Size, Share & Trends Analysis Report By Deployment Mode, By Monitoring Type (Therapeutic Data, Non-Physiological Data), By End Use (Healthcare Providers, Patients & Caregivers), And Segment Forecasts

U.S. Remote Therapeutic Monitoring Market Summary

In addition, artificial intelligence (AI) supported remote therapeutic monitoring (RTM) platforms enable more accurate, efficient, and personalized monitoring of patients' therapeutic progress by leveraging advanced data analytics, machine learning, and real-time feedback.

Source: Grand View Research, IR Documents, Primary Interviews, Paid Databases

To learn more about this report, Download Free Sample Report

The section below outlines key market factors, including the rising prevalence of chronic diseases and trends shaping the remote therapeutic monitoring market. It reflects cost reduction potential, insurance, and reimbursement policies supporting the market growth.

Telehealth Expansion

The rapid expansion of telehealth services in the U.S. is a major driver for the adoption of remote therapeutic monitoring (RTM). The widespread use of virtual care platforms is supported by policy changes from the Centers for Medicare & Medicaid Services. Telehealth enables healthcare providers to remotely assess patient progress, adjust treatment plans, and intervene in real time using data generated through RTM solutions. For instance, in February 2025, NowPatient partnered with Lifelight to enhance its telehealth platform by integrating smartphone-based monitoring and continuous health tracking. This innovation enables remote blood pressure measurement using only a smartphone, eliminating the need for wearables or cuffs and removing a major barrier to telehealth adoption.

CPT Codes for RTM and RTM Treatment Management Services

Source: Centers for Medicare and Medicaid Services (CMS 2022)

Funding/Investments in U.S. Remote Therapeutic Monitoring (RTM) Market 

Market Dynamics

Market Characteristics & Concentration

The chart below represents the relationship between industry concentration, industry characteristics, and industry participants. There is a high degree of innovation, a moderate level of mergers & acquisitions, a high impact of regulations, and moderate product expansion.

To learn more about this report, Download Free Sample Report

Market Dynamics

The U.S. remote therapeutic monitoring (RTM) market is moderately concentrated, with many players entering the market and launching new innovative products. The degree of innovation is high, and the level of merger & acquisitions activities is medium. The impact of regulations on the market is high, and the product expansion is medium.

The U.S. Remote Therapeutic Monitoring (RTM) industry experiences a high degree of innovation driven by technological advancements. Integrating artificial intelligence into these systems enables more informed decision-making about treatment adjustments and interventions. For instance, in December 2025, PhyxUp Health launched an AI-powered Remote Therapeutic Monitoring (RTM) platform designed specifically for rehabilitation providers. The platform enables clinicians to remotely monitor therapy adherence, track patient progress between visits, and receive real-time insights for clinical decision-making.

The industry is experiencing a moderate level of merger and acquisition activities undertaken by several key players. This is due to the desire to gain a competitive advantage in the industry, enhance technological capabilities, and consolidate in a rapidly growing market. For instance, in June 2025, CoachCare acquired MD Revolution as part of its ongoing consolidation strategy in the remote care and RTM market.

The regulatory landscape plays a critical role in shaping the U.S. Remote Therapeutic Monitoring (RTM) market by ensuring the devices and services meet safety, efficacy, and privacy standards. Compliance with medical device regulations, reimbursement policies, data security standards, and clinical validation requirements is essential for the widespread adoption of RTM technologies. In the U.S., HIPAA sets standards for protecting patient data.

The industry is witnessing moderate product expansion, driven by an increasing customer base for remote therapeutic monitoring software and solutions. Firms are aligning with technology providers and consulting agencies to enhance their product offerings and expand market reach. For instance, in December 2025, PhyxUp Health expanded its product portfolio by launching an AI-powered Remote Therapeutic Monitoring (RTM) platform designed for rehabilitation providers across the U.S. 

Deployment Mode Insights

The web & cloud-based segment dominated the U.S. remote therapeutic monitoring (RTM) industry, accounting for the largest share of 75.1% in 2025, and is expected to grow at the fastest CAGR from 2026 to 2033. Web and cloud-based deployments allow healthcare providers and patients to access monitoring tools from anywhere with an internet connection. Cloud computing facilitates real-time data collection and analysis, which is essential for effective remote therapeutic monitoring. For instance, in February 2026, Net Health announced the expansion of its RTM capabilities through the scaling of Limber Health as a cloud-based outcomes and remote therapeutic monitoring platform. By using cloud platforms, healthcare providers continuously gather patient data from various connected devices, such as wearables and mobile applications. The ability to analyze this data in real time enables immediate interventions when necessary, improving patient safety and the quality of care.

The on-premise segment is expected to grow at the fastest CAGR from 2026 to 2033, driven by healthcare providers prioritizing data security, regulatory control, and integration with existing hospital IT infrastructure. On-premises RTM solutions are deployed on the healthcare organization’s internal servers, enabling full ownership and governance of sensitive patient data. The model is particularly preferred by large hospital systems, integrated delivery networks (IDNs), and rehabilitation centers that already maintain robust IT infrastructure and require strict compliance with data privacy regulations such as HIPAA.

Monitoring Type Insights

The therapeutic segment dominated the U.S. remote therapeutic monitoring (RTM) market in 2025, accounting for the largest revenue share of 70.4%. One of the key advantages of collecting therapeutic data is its potential to enhance patient engagement. Therapeutic data enables real-time monitoring of patient progress. By continuously tracking how patients respond to treatments, healthcare providers are anticipated to make timely adjustments to therapy plans based on actual performance rather than relying solely on periodic office visits or assessments. This dynamic approach is expected to significantly enhance the effectiveness of treatment protocols by ensuring that interventions are promptly tailored to meet individual patient needs.

Furthermore, the non-physiological data segment is expected to grow at the fastest CAGR from 2026 to 2033. The non-physiological data allows healthcare professionals to monitor the physical aspects of a patient’s condition and the psychological and behavioral factors that influence health outcomes. The integration of non-physiological data into remote therapeutic monitoring supports comprehensive care models that prioritize holistic patient management. By considering both physiological and non-physiological factors, healthcare systems develop more robust strategies to manage chronic conditions, thereby improving the quality of care and patient satisfaction.

End Use Insights

The healthcare providers segment dominated the U.S. remote therapeutic monitoring (RTM) industry, accounting for the largest share of 45.16% in 2025. Healthcare providers utilize RTM tools to enhance patient care by continuously monitoring patients’ health conditions. This is beneficial for managing chronic diseases such as diabetes, hypertension, and heart disease. Moreover, RTM facilitates better communication between patients and healthcare providers. Through remote monitoring systems, providers engage with patients more frequently without requiring them to visit a clinic. For instance, an article published in June 2025 on PubMed highlighted a total of 13 529 594 remote-monitoring services that occurred between 2019 and 2023. In addition, the integration of RTM into clinical practice allows healthcare providers to leverage data analytics for informed decision-making. With access to comprehensive health data collected remotely, clinicians are anticipated to identify trends and patterns that may indicate worsening conditions or treatment efficacy, enabling personalized treatment plans.

To learn more about this report, Download Free Sample Report

The patients & caregivers segment is anticipated to grow at the fastest CAGR from 2025 to 2033. Similarly, the payers segment is anticipated to grow significantly during the forecast period. The implementation of RTM allows players to manage healthcare costs more efficiently. Payers are anticipated to influence the adoption of RTM by offering flexible reimbursement policies. By allowing providers to bill for remote monitoring services at rates similar to those for in-person visits, payers incentivize the integration of these technologies into routine care. This financial support encourages providers to utilize RTM solutions more effectively.

Country Insights

The U.S. Remote Therapeutic Monitoring (RTM) industry is experiencing significant growth, advanced healthcare infrastructure, and technological advancements. Moreover, increasing adoption of telemedicine and telehealth solutions contributes to market growth. For instance, in 2025, Hinge Health expanded its hybrid musculoskeletal (MSK) care model across the U.S., integrating virtual physical therapy, AI-driven coaching, and remote therapeutic monitoring (RTM) with optional in-person care pathways. The advancements in AI and the increasing demand for remote therapeutic monitoring are further driving the growth.

Key U.S. Remote Therapeutic Monitoring (RTM) Company Insights

Key players operating in the U.S. Remote Therapeutic Monitoring (RTM) Market are undertaking various initiatives to strengthen their market presence and increase the reach of their products and services. Strategies such as new product launches and partnerships are playing a key role in propelling the market growth. 

Recent Developments

• In January 2026, CMS finalized updates to the Remote Therapeutic Monitoring (RTM) reimbursement framework, introducing new CPT codes for musculoskeletal RTM (98985, 98979) and lowering data collection thresholds to improve adoption across rehab and MSK care settings.

• In February 2026, Net Health expanded its Limber Health platform, scaling it as a cloud-based outcomes, home exercise, and RTM-enabled system for rehab therapy providers across the United States.

• In February 2025, Fyzical Therapy Balance Centers partnered with Sara Health to enhance patient care through remote therapeutic monitoring. The initiative focuses on improving outcomes for patients with balance and mobility issues through innovative technology.

“SaRA Health's platform significantly enhances patient care by allowing for seamless remote monitoring and communication,”

-Scott Gardner, a three-unit FYZICAL Franchise owner and Franchise Advisory Council President.

“Patients appreciate the ease through which they can interact with their therapists, which in turn fosters better adherence to treatment plans. Therapists benefit from integrating SaRA Health into their workflow, enabling more timely support. At the same time, practice owners see greater patient satisfaction, higher plan-of-care completion rates, and an additional source of revenue, which they in turn, can share with clinicians.”

• In January 2025, Adhere+ launched Spanish-language integration for its remote therapeutic monitoring platform, enhancing healthcare equity and accessibility.

"This is a potentially transformational moment for my Spanish-speaking patients,"

-Dr. Gerald Ho, board-certified rheumatologist at the California-based Arthritis and Osteoporosis Medical Center.

"The Spanish-language integration on the Adhere+ platform allows me to extend RTM usage to my patients when English is not their first language.  This allows them to engage with their care plans in a way that feels intuitive and empowering.  It is a vital step that will help bridge critical gaps in communication, foster stronger patient-provider relationships, and help transform how we deliver care to diverse populations."

• In November 2024, SoundHealth launched SONUCheck, an innovative feature in its SONU app. This feature enhances therapeutic monitoring by utilizing vocal analysis to assess nasal breathing.

U.S. Remote Therapeutic Monitoring Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. remote therapeutic monitoring market report based on deployment mode, monitoring type, and end use:

• Deployment Mode Outlook (Revenue, USD Million, 2021 - 2033)

  • Cloud & Web based

  • On-premise

• Monitoring Type Outlook (Revenue, USD Million, 2021 - 2033)

  • Therapeutic Data

  • Non-Physiological Data

• End Use Outlook (Revenue, USD Million, 2021 - 2033)

  • Healthcare Providers

  • Home Healthcare

  • Patients & Caregivers

  • Payers